Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-29

Clinical Trial Update: AM-101 in the Treatment of Acute Tinnitus 2 [Phase 3]

View source ↗

Summary

Auris Medical reported Phase 3 results for AM-101 in acute tinnitus. The trial was completed and results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AM 101

Snippet

Sponsor: Auris Medical, Inc. | Conditions: Tinnitus | Phase 3 | Status: COMPLETED | Results posted: 2018-05-29